JPRN-UMIN000007881已完成未知
Phase I randomized study of 0.15% UF-021 in patients with geographic atrophy treated after wet age-related macular degeneration - Phase I Study of 0.15% UF-021 in patients with geographic atrophy treated after wet AMD
Dept. of Ophthalmology, Kagawa university faculty of medicine0 个研究点目标入组 50 人开始时间: 2012年5月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Photocoagulation scar around macula Glaucoma, vitreous opacity, optic neuropathy Uncontrollable diabetes, myocardiac infarction, angina, pregnancy
研究者
相似试验
未知
2 期
Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosaretinitis pigmentosaJPRN-jRCT2080220721R-Tech Ueno, Ltd105
招募中
2 期
A phaseII randomized trial of UFT for the patients completely resected pathological Breast cancerBreast cancerJPRN-UMIN000004586Ryukyu Breast Club140
已完成
2 期
Randomized phase II study of clinical effect of ultrasonically activated coagulating shears (Harmonic scalpel) for open gastrectomy.Gastric cancerJPRN-UMIN000003303Multicenter Clinical Study Group of Osaka (MCSGO)230
进行中（未招募）
不适用
A Dose Targeted Phase I/II Study To Evaluate The Feasibility, Safety, And Biological Effects Of Intravenous Administration of A Wild-Type Reovirus (REOLYSIN®) in Combination With Paclitaxel and Carboplatin To Patients With Advanced MalignanciesAdvanced or metastatic solid tumours that are refractory to standard therapy or for which no curative standard therapy exists and for which paclitaxel plus carboplatin is appropriate palliative chemotherapy.MedDRA version: 8.1Level: LLTClassification code 10049280Term: Solid tumourEUCTR2006-006515-76-GBOncolytics Biotech Inc
已完成
1 期
A study in healthy volunteers to investigate how the test medicine CORT113176 is taken up by the body when given with food and without foodAmyotrophic lateral sclerosis (ALS)Nervous System DiseasesMotor neuron diseaseISRCTN52169163Corcept Therapeutics (United States)35